IGF1 and microcephaly: Importantly, pharmacological treatment with insulin-like growth factor-1 (IGF-1) ligand known to activate these pathways rescued microcephaly and neuronal outgrowth defect in this model, suggesting a possible therapeutic strategy for mitigating the deficiencies phenotypes associated with DYRK1A deficiency syndrome.